• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070300-48
Device Problems Improper or Incorrect Procedure or Method (2017); Component Missing (2306)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/09/2021
Event Type  malfunction  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a lesion in the mildly calcified, moderately tortuous, 80% stenosed proximal left anterior descending coronary artery.After pre-dilatation with unspecified 1.2x8mm and 2x8mm balloons, a 3x48mm xience xpedition stent delivery system (sds) was advanced.During deployment, it was noted that there was no stent present on the device.Per hospital staff, they did not notice whether the stent was present on the sds prior to advancement in patient anatomy.A same sized xience xpedition stent was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
It was reported that the procedure was performed to treat a lesion in the mildly calcified, moderately tortuous, 80% stenosed proximal left anterior descending coronary artery.After pre-dilatation with unspecified 1.2x8mm and 2x8mm balloons, a 3x48mm xience xpedition stent delivery system (sds) was advanced.During deployment, it was noted that there was no stent present on the device.Per hospital staff, they did not notice whether the stent was present on the sds prior to advancement in patient anatomy.A same sized xience xpedition stent was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.Subsequent to the initially filed mdr report, the account confirmed the xience xpedition was prepped prior to sheath/stylet removal.No additional information was provided.
 
Manufacturer Narrative
Device code 2017 - incorrect prep a visual inspection was performed on the returned device.The reported missing component was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported that the xience xpedition was prepped prior to sheath/stylet removal.It should be noted that the xience xpedition, everolimus eluting coronary stent system (eecss) instructions for use specifies to remove the product mandrel and protective stent sheath by grasping the catheter just proximal to the stent (at the proximal balloon bond site), and with the other hand, grasp the stent protector and gently remove distally.Ifu states: flush the guide wire lumen with hepns using the flushing tool supplied with the product.In addition, it was reported that the stent implant was not on the balloon after the device had been advanced into the anatomy.It should be noted that the xience xpedition, everolimus eluting coronary stent system (eecss) instructions for use states: prior to using the xience xpedition 48 everolimus eluting coronary stent system, carefully remove the system from the package and inspect for bends, kinks, and other damage.Verify that the stent does not extend beyond the radiopaque balloon markers.The investigation was unable to determine a conclusive cause for the reported missing components.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12605419
MDR Text Key277199848
Report Number2024168-2021-09052
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1070300-48
Device Lot Number1041341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-